ROSE

First Oncology Dogtor Prediction

ROSE
Solana
AI Analysis
May 4, 03:49 AM

Gr5N2EecbtP4156TWvKaHH4fy2rn8TH2M7cAaTpdpump

$0.0000017933

-29.32%

FDV $1,793

FDV

$1,793

Liquidity

$0

Holders

37

Snipers

35

Risk

Very High

AI Executive Summary

First Oncology Dogtor (ROSE) is an ultra-micro-cap Solana meme token launched on PumpSwap, themed around a cancer-detection beagle named Rose. With a fully diluted valuation of ~$1,793 and only 37 holders, this is an extremely early-stage, highly speculative token exhibiting severe sell pressure, near-zero liquidity, and extreme supply concentration. The top holder (the PumpSwap liquidity pool address HsTWUzpDTwD5UNEQ7YAeL5XNkvSH3mAM9uBFGYrmeyfb) controls 90.84% of supply, leaving virtually no float. The token lost 29.3% of its value in 24 hours and recorded zero buys in the same period.

Risk: Very High
Sentiment: Bearish
Unique cancer-detection dog narrative tied to a real-world concept (Dognosis canine team)
Launched on PumpSwap with social presence (Twitter, website, Moralis)
Extremely low FDV (~$1,793) — near-zero market cap with high asymmetric upside potential if narrative catches on
Mutable flag is false, suggesting immutable metadata

Price Prediction

bearish

Short term

bearish
24–72 hours

With zero buys in the last 24 hours, 100% sell pressure, 9 sell transactions from 7 unique sellers, and a -29.3% price drop, the short-term outlook is decisively bearish. The price has been grinding down from ~$0.00000183 (candle [5]) to ~$0.00000179 (current), with no meaningful buy-side support. The 5m/1h/6h price changes are all 0%, indicating a frozen market with no active trading.

Target low$0.00000100
Target high$0.00000183
Support: $0.00000179 (current price / recent close), $0.00000150 (psychological round level), $0.00000100 (critical floor)
Resistance: $0.00000183 (recent candle high, candles [4] and [5]), $0.00000182 (candle [3] open), $0.00000200 (psychological resistance)

Medium term

neutral
7–30 days

Medium-term direction is highly uncertain. The token sat dormant with only 2 holders for the entire month of April before spiking to 46 holders on May 2 and then declining to 37 on May 3. Without sustained community growth, new liquidity injection, or viral narrative momentum, the token is likely to continue declining or go dormant again. A recovery is possible only if the cancer-detection dog narrative gains traction on social media.

Catalysts
  • Viral social media moment around the Dognosis/cancer-detection dog narrative
  • New liquidity providers entering the PumpSwap pool
  • Broader Solana meme coin market rally lifting micro-caps
  • Influencer or KOL promotion

Bullish factors

  • Unique and emotionally resonant narrative (cancer-detection dog)
  • Very low FDV (~$1,793) means small capital inflows could produce large percentage gains
  • Social links (Twitter, website) suggest some level of project organization
  • Immutable metadata (mutable: false) reduces certain rug vectors

Bearish factors

  • 100% sell pressure in last 24 hours with zero buyers
  • -29.3% price decline in 24 hours
  • Reported total liquidity of $0.00 — effectively no exit liquidity
  • Only 37 holders, down 8 (-22%) in 24 hours
  • Top holder (likely LP pool) controls 90.84% of supply
  • Token was dormant for ~30 days with only 2 holders before brief spike
  • Majority of snipers (12 of 20) are at a realized loss
  • Unverified contract
Confidence: low. Confidence is low due to the extremely thin trading history (token was dormant for ~30 days with 2 holders), near-zero liquidity ($0.00 reported), only 37 holders, and 100% sell pressure in the last 24 hours. Price discovery is essentially non-existent at this stage.

Deep Analysis

Technical Analysis
Holder Trends
Whale Map
Risk Assessment
Investment Thesis

Unlock Full AI Analysis

Sign up to access technical analysis, whale maps, risk assessment, holder trends, and more

Token Info

ChainSolana
Contract
Total Supply999,996,119.75 ROSE

Key Risks

Near-zero liquidity ($0.00 reported) makes exit extremely difficult
100% sell pressure with zero buyers in last 24 hours
Extreme supply concentration — top 10 hold 99.75%
Only 37 holders, declining rapidly (-22% in 24h)

Smart Money & Sniper Analysis

low confidence
Low risk

Of 20 identified snipers, the majority have already sold their positions. The largest sniper (AgmLJBMDCqWynYnQiPCuj9ewsNNsBJXyzoUhD9LJzN51) sold $5,176 at a -23.3% realized loss, suggesting they bought at a higher price and dumped. Of the 20 snipers with known PnL data: 8 are in profit (positive realized PnL%), 11 are at a loss, and 1 is at breakeven. The sell-through rate is high — most snipers have exited. The one remaining sniper with a balance (BZrwstteiRdjNR9kyudcFYGVyGAxwRv2Q7G7tm4gMjsi, $112) is at 0% realized PnL, suggesting they haven't sold yet. Overall smart money sentiment is negative — early buyers mostly sold at a loss, indicating the token failed to sustain its initial pump.

AI-generated insight. Not financial advice.

Sniper details

Sniper concentration2.00%
PnL stateMixed
Sell-through rateHigh
Profit-taking risk
low

Only sniper [10] BZrwstteiRdjNR9kyudcFYGVyGAxwRv2Q7G7tm4gMjsi has a known remaining balance (~$112), appearing as holder #7 with 0.26% of supply. The largest sniper by sell volume was AgmLJBMDCqWynYnQiPCuj9ewsNNsBJXyzoUhD9LJzN51 who sold $5,176 — the dominant exit. Most snipers have fully exited.

Predominantly negative. 11 of 20 snipers realized losses, with extreme losses recorded: EXCB6Xvb2qRWReiX22BcbXqpx5L9SfVLnKZsiGVPWQnq (-90.2%), 5B6URc6f6Lv5GCH53EkhFvS4WphyxaxH1ZKbkq1dRKxY (-77.7%), DZbgq3yE3r41EFszV3XastvyS8j8QnmNT37nsq7sxR66 (-53.8%), CkUZV387xnoGpF7wC2moMa6mPmAgCvTT4pWgzq4M9fCD (-32.6%). Only 8 snipers are in profit, with modest gains (3.3% to 39.0%).

Frequently Asked Questions

What is the price prediction for First Oncology Dogtor (ROSE)?

With zero buys in the last 24 hours, 100% sell pressure, 9 sell transactions from 7 unique sellers, and a -29.3% price drop, the short-term outlook is decisively bearish. The price has been grinding down from ~$0.00000183 (candle [5]) to ~$0.00000179 (current), with no meaningful buy-side support. The 5m/1h/6h price changes are all 0%, indicating a frozen market with no active trading. Short-term outlook is bearish (24–72 hours), with a target range of $0.00000100 to $0.00000183.

Is ROSE a safe investment on Solana?

Overall risk is rated very_high with a risk score of 9.2/100. Suitable ONLY for highly experienced, risk-tolerant speculators who treat this as a lottery ticket with near-total loss probability. Absolutely not suitable for risk-averse investors, those investing more than they can afford to lose completely, or anyone seeking stable returns. Position sizing should reflect the realistic probability of total loss.

How are ROSE holders trending?

First Oncology Dogtor currently has 37 holders and is declining (24h: -22, 7d: 95, 30d: 95). The holder history reveals a token that was completely dormant from April 4 through May 1, with only 2 holders (likely the deployer and one other). On May 2, holders surged from 2 to 46 (+44, +96%) — the token's launch/activation event. By May 3, holders dropped to 37 (-9, -24%), indicating rapid early holder attrition. The 7d and 30d growth figures of +95% (+35 holders) are technically positive but misleading — they reflect the single launch spike, not sustained organic growth. The trend is now declining, with 8 holders lost in 24 hours and no new buyers recorded in the last 24h trading data.

What does sniper activity look like for ROSE?

Snipers hold roughly 2.00% of supply with PnL state "mixed" and sell-through rate "high". Profit-taking risk: low.

What are the key risks of holding ROSE?

Near-zero liquidity ($0.00 reported) makes exit extremely difficult • 100% sell pressure with zero buyers in last 24 hours • Extreme supply concentration — top 10 hold 99.75%

More tokens on Solana

Get AI insights for ROSE